Innovative Immunotherapy: CAR T-Cell Therapy Market Trends and Forecasts
Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that uses the body's own immune system to fight cancer. In CAR T-cell therapy market , T cells are removed from the patient's blood, genetically engineered to express a chimeric antigen receptor (CAR), and then infused back into the patient. The CAR is designed to recognize a specific cancer antigen, and the T cells are...
0 Comments 0 Shares